Lexpos News

We have issued the following clarification on the 2024/25 Community Pharmacy Contractual Framework (CPCF) negotiations. Our Chief Executive Janet Morrison said: “Government purdah effectively began as soon as the Prime Minister announced the General Election. Whilst discussions can continue no formal agreement can be reached until after the election and new Ministers are appointed. Current [...]

The post CPCF negotiations during the election period appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health of Social Care (DHSC) has re-determined the special container status of Drospirenone (Slynd®) 4mg tablets. From 1 June 2024, Drospirenone (Slynd®) 4mg tablets were re-classified as a special container at sub-pack level (sub-pack of 28) as they meet the relevant criteria as set out in Part II [...]

The post Drospirenone (Slynd®) 4mg tablets re-classified as a special container appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Betamethasone Valerate 0.1% Ointment (Manx Healthcare Ltd.) Drug alert number: EL (24)A/18 Date issued: 03 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Betamethasone Valerate 0.1% Ointment (Manx Healthcare Ltd.) Company name: Manx Healthcare Ltd. Product name: Betamethasone Valerate [...]

The post MHRA Class 4 Medicines Defect Information: Betamethasone Valerate 0.1% Ointment (Manx Healthcare Ltd.) appeared first on Community Pharmacy England.

Community pharmacy owners are being asked to share information on the pressures on their businesses, as well as their key messages for the new Government, ahead of the next full Community Pharmacy England Committee meeting at the end of June. A key focus of this committee meeting will be the General Election campaign and plans [...]

The post Tell us about the pressures on your business: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

A recent report published by Healthwatch England highlights that the cost of living pressures are affecting people’s ability to afford prescription and over-the-counter medicines.  Freedom of Information data from 2021, found that over a million people could have saved money through NHS prescription prepayment certificates (PPCs). Therefore, Healthwatch England is calling for improvements to NHS [...]

The post Promoting NHS prescription prepayment certificates appeared first on Community Pharmacy England.